Team | Year | Pos | G | IP | PO | A | E | Fld % | RF | Eff | ZR |
---|---|---|---|---|---|---|---|---|---|---|---|
Chestermere - SNL (R)
CHS - SNL (R)
|
2053 | SS | 1 | 1.0 | 0 | 1 | 1 | .500 | 9.00 | .755 | -0.43 |
Chestermere - SNL (R)
CHS - SNL (R)
|
2053 | LF | 3 | 8.1 | 0 | 0 | 0 | .000 | 0.00 | .000 | 0.00 |
Chestermere - SNL (R)
CHS - SNL (R)
|
2053 | RF | 8 | 27.0 | 8 | 1 | 1 | .900 | 3.00 | .913 | -0.57 |
Chestermere - SNL (R)
CHS - SNL (R)
|
2052 | LF | 4 | 13.0 | 0 | 0 | 0 | .000 | 0.00 | .000 | -0.23 |
Chestermere - SNL (R)
CHS - SNL (R)
|
2052 | CF | 1 | 3.0 | 0 | 0 | 0 | .000 | 0.00 | .000 | 0.00 |
Chestermere - SNL (R)
CHS - SNL (R)
|
2052 | RF | 7 | 25.0 | 6 | 0 | 0 | 1.000 | 2.16 | 1.024 | 0.27 |
Merrill Lynch - HSAS (HS)
ML - HSAS (HS)
|
2051 | LF | 6 | 45.0 | 10 | 0 | 0 | 1.000 | 2.00 | 1.056 | 0.61 |
Merrill Lynch - HSAS (HS)
ML - HSAS (HS)
|
2051 | CF | 1 | 9.0 | 1 | 0 | 1 | .500 | 1.00 | .716 | -0.68 |
Merrill Lynch - HSAS (HS)
ML - HSAS (HS)
|
2051 | RF | 11 | 93.0 | 15 | 0 | 0 | 1.000 | 1.45 | 1.060 | 0.75 |
Merrill Lynch - HSAS (HS)
ML - HSAS (HS)
|
2050 | LF | 4 | 36.0 | 7 | 0 | 0 | 1.000 | 1.75 | .999 | 0.36 |
Merrill Lynch - HSAS (HS)
ML - HSAS (HS)
|
2050 | CF | 7 | 38.0 | 7 | 0 | 1 | .875 | 1.66 | .824 | -0.95 |
Merrill Lynch - HSAS (HS)
ML - HSAS (HS)
|
2050 | RF | 1 | 1.0 | 0 | 0 | 0 | .000 | 0.00 | .000 | 0.00 |
Total | SS | 1 | 1.0 | 0 | 1 | 1 | -0.43 | ||||
Total | LF | 17 | 102.1 | 17 | 0 | 0 | 0.73 | ||||
Total | CF | 9 | 50.0 | 8 | 0 | 2 | -1.63 | ||||
Total | RF | 27 | 146.0 | 29 | 1 | 1 | 0.45 |